Article
Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs.
Gene therapy - 1 Sept 2007
Knecht W, Rozpedowska E, Le Breton C, Willer M, Gojkovic Z, Sandrini M P B, Joergensen T, Hasholt L, Munch-Petersen B, Piskur J
Abstract excerpt
Transduced deoxyribonucleoside kinases (dNK) can be used to kill recipient cells in combination with nucleoside prodrugs. The Drosophila melanogaster multisubstrate dNK (Dm-dNK) displays a superior turnover rate and has a great plasticity regarding its substrates. We used directed evolution to create Dm-dNK mutants with increased specificity for several nucleoside analogs (NAs) used as anticancer or antiviral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
